Oncology News | pharmaphorum

News

Roche sticks with molecular glue, partnering Monte Rosa

Roche seems determined to develop a commanding position in the emerging molecular glue category, signing up to a $2 billion partnership with Monte Rosa Therapeutics that i

News

Nucleus RadioPharma raises $56m in first round financing

There’s a new kid on the block in the fast-growing radiopharmaceuticals category, as Nucleus RadioPharma chalks up an oversubscribed Series A that raised $56 million that

News

Keytruda gets surgery-spanning OK from FDA in early NSCLC

MSD’s Keytruda has become the first immunotherapy in the US that can be used continuously, before and after surgery, in patients with early-stage non-small cell lung cance

News

AZ’s Tagrisso plus chemo get fast FDA review for lung cancer

AstraZeneca will hear back from the FDA in the first quarter of next year about its recent filing of Tagrisso in combination with chemotherapy as a first-line treatment fo

News

Faron’s Clever-1 drug shows promise in blood cancers

Faron Pharmaceuticals has reported data from a phase 1/2 trial pointing to the potential of its macrophage-directed antibody bexmarilimab as a treatment for blood cancers

News

Scotland first in Europe to back MSD drug for VHL tumours

Scotland has become the first country in Europe to recommend coverage of MSD’s Welireg as a treatment for some people with von Hippel-Lindau disease (VHL), a rare genetic

Roche sticks with molecular glue, partnering Monte Rosa

Nucleus RadioPharma raises $56m in first round financing

Keytruda gets surgery-spanning OK from FDA in early NSCLC

AZ’s Tagrisso plus chemo get fast FDA review for lung cancer

Faron’s Clever-1 drug shows promise in blood cancers

Scotland first in Europe to back MSD drug for VHL tumours

23andMe study explains variable results with obesity drugs

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks